Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a trend rather than a single value.
Background: eight months on tirzepatide, uneventful until a bad fortnight of vomiting and diarrhoea after a dose increase, during which I ate very little and drank…
I have the full paper rather than the abstract, and the supplementary appendix. I can parse the result. I am less sure what it licenses me to conclude. I have…
Details up front: albumin-to-creatinine ratio · sixteen weeks · tirzepatide. I have a result I cannot explain, and I would rather diagnose it than guess. I have…
For reference: triglycerides · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
I have been offered "a full panel" and I would rather understand what I am asking for than collect numbers I cannot interpret. My concern is specifically that active…
What I am working with: ALT · mazdutide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
What I am working with: LDL-C · triglycerides · semaglutide. Both of these get recommended confidently by different people, which suggests neither is obviously right.…
Stated plainly: lipase · a GLP-1 receptor agonist. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
What I have: TSH · dulaglutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident the…
Numbers first: a GLP-1 receptor agonist · sixteen weeks. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I would like to know the limits of what can be inferred…
What I have: survodutide · four weeks. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
Details up front: dulaglutide · two weeks. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the…
The clinician who ordered the panel was not concerned; I would still like to understand it. I would like to set this up properly once, rather than adjust it…
The case in front of me: HbA1c · liraglutide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically,…
For reference: LDL-C · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my tolerance…
Conditions: potassium · semaglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come…
Details up front: ApoB · retatrutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
Concretely: ecnoglutide · four weeks. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
My HbA1c went from 7.4% to 6.9% over four months on semaglutide. Everyone tells me half a point is good. Nobody has told me what half a point is , in units I can…
What I am working with: LDL-C · eight weeks · ecnoglutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not…
What I am working with: potassium · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit…
For reference: ferritin · ApoB · retatrutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the…
Details up front: cagrilintide · six weeks. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse results